IP vs SABSW · P/E 43, $26.62B cap vs P/E 0.0, rev $1.3M
International Paper (IP) versus SAB Biotherapeutics Inc (SABSW) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
SAB Biotherapeutics Inc (SABSW) common stock listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported SABSW revenue for 2024-12-31 was $1.3M. Net income was -$34.1M. Revenue was down 40.9% from 2023-12-31 to 2024-12-31. SABSW currently screens at market cap $0 and trailing P/E 0.0.
IP currently screens at market cap $26.62B and trailing P/E 43.1. SABSW currently screens at market cap $0 and trailing P/E 0.0.
Not investment advice. Open the IP and SABSW stock pages for the full models.
Not investment advice.